A total of 2,500 exhibitors from 150 countries await the visit of 37,000 professionals
Fira de Barcelona is hosting CPhI Worldwide, the world’s most important trade show for the pharmaceutical sector
The leading pharmaceutical industry trade show has chosen Fira de Barcelona to hold its 2016 world event. From 4 to 6 October, CPhI Worldwide, organised by UBM EMEA, will be bringing together 2,500 exhibiting companies from 150 countries, filling the whole of the Gran Via site, and is expected to attract 37,000 professionals.
CPhI Worldwide is the leading international trade fair in the pharmaceutical and chemical industry, attended by managers and executives from the 50 largest companies in the world. For three days, in the eight pavilions at the Gran Vía venue, it will be presenting the latest in ingredients, excipients, chemical products services, equipment, machinery, technology and solutions for the handling and packaging of medicinal products.
The trade show has also created new spaces specialising in outsourcing pharmaceutical and logistic services (ICSE), packaging (InnoPack); instrumental analysis, measurement, lab test and quality control technologies and companies (P-MEC Europe), and all aspects of the supply chain and licence application (Finished Dose Formulation).
As well as the exhibition area, CPhI Worldwide offers an outstanding congress programme, with the participation of over 120 world-renowned speakers. This year, innovation, contractual services and the patient are just some of the topics covered in the sessions.
New business opportunities
Having held the show in Madrid on four occasions in the last decade, the organisers of CPhI Worldwide have chosen Barcelona as this year’s venue for their world event, while there are other specific shows in Korea, China, India, Japan, south-east Asia, Istanbul, Russia and the United States.
Its arrival at Fira de Barcelona strengthens the institution’s strategy of attracting major international events while also providing business opportunities for domestic pharmaceutical companies and for the city, as the organisers estimate the trade show will have an economic impact of EUR 150 million.
According to Chris Kilbee, director of UBM EMEA Pharma Group, ‘Barcelona has become a new centre for innovation, with a flourishing biotech industry and an outstanding R&D&I investment plan, so hosting this event is, without doubt, a new and major step forward in developments in this field in both the city and Catalonia.’
Spain is the fifth largest pharmeceutical market in Europe: the sector represents 1.4% of the country’s GDP and creates around 37,000 jobs. Almost half of R&D&I investment (47%) and over 20% of Spanish biotech companies are based in Barcelona and its area of influence.
Barcelona, 26 September 2016
CPhI Press – Facto Communications
Alex Heeley / Nadine Caillaux
T: +44 (0) 203 735 8168 / Email: a.heeley@defacto.com / n.caillaux@defacto.com